Correlation Between Valneva SE and Neurosense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Neurosense Therapeutics, you can compare the effects of market volatilities on Valneva SE and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Neurosense Therapeutics.
Diversification Opportunities for Valneva SE and Neurosense Therapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Valneva and Neurosense is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Neurosense Therapeutics go up and down completely randomly.
Pair Corralation between Valneva SE and Neurosense Therapeutics
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Neurosense Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.26 times less risky than Neurosense Therapeutics. The stock trades about -0.62 of its potential returns per unit of risk. The Neurosense Therapeutics is currently generating about -0.43 of returns per unit of risk over similar time horizon. If you would invest 134.00 in Neurosense Therapeutics on August 30, 2024 and sell it today you would lose (41.00) from holding Neurosense Therapeutics or give up 30.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valneva SE ADR vs. Neurosense Therapeutics
Performance |
| Timeline |
| Valneva SE ADR |
| Neurosense Therapeutics |
Valneva SE and Neurosense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Neurosense Therapeutics
The main advantage of trading using opposite Valneva SE and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.| Valneva SE vs. Bright Minds Biosciences | Valneva SE vs. HP Inc | Valneva SE vs. Intel | Valneva SE vs. Chevron Corp |
| Neurosense Therapeutics vs. Bright Minds Biosciences | Neurosense Therapeutics vs. HP Inc | Neurosense Therapeutics vs. Intel | Neurosense Therapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |